Adcendo
PrivateLast Round
Series C
Apr 14, 2026
Est. Valuation
$332,367
Total Funding Raised
$324.71M
Company Overview
Adcendo is a biopharmaceutical company that develops antibody-drug conjugates aimed at creating innovative treatments for cancer patients facing significant unmet medical needs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Adcendo Comps
Public and private peers based on sector, stage, and business model.
Adcendo Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Apr 14, 2026 | ||||
| Series B | Nov 25, 2024 | ||||
| Series A Extension | May 29, 2024 | ||||
| Series A Extension | Apr 4, 2023 | ||||
| Series A | Apr 29, 2021 | ||||
Convertible Debt | Aug 29, 2019 |
Key People
Founding team and executive leadership
Adcendo Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TPG Life Sciences Innovations | Series B |
| Surveyor Capital | Series C |
| RA Capital Management | Series A, Series A Extension, Series C, Series B |
| TCG Crossover | Series C, Series B |
| Kohlberg Kravis Roberts | Series C |
| Novo Seeds | Grant, Series A |
| Ysios Capital | Series A Extension, Series C, Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 14, 2026
Rajul Jain from Vida Ventures joins the Board of Directors.
- Apr 14, 2026
Ksenija Pavletic joins the board, coming from Jeito Capital.
Adcendo Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Adcendo's valuation, stock price, and market status.
